tirzepatide phase 3 trial as Compared with Semaglutide for the Treatment of Obesity Overview of the SURPASS phase

MoldCo Raises $8M To Make Mold Detox Part of Preventive Care MoldCo has secured $8M in seed funding to expand its telehealth platform and make mold detox as routine as a physical or dental exam

The consistency of GLP-1 effectiveness across alcohol, opioids, cocaine, nicotine, and cannabis suggests these drugs may act on a shared vulnerability underlying addiction not on any single substance pathway

Targeting BFCN degeneration may also improve gait in PD, given previous evidence in this field [156, 157]

Consistently, elevated glucose levels, impaired glucose tolerance, reduced insulin levels, decreased plasma levels of GLP-1, and downregulated mRNA expression of ileal Gcg were observed in MMI mice compared to untreated control mice (CT mice) (Supplementary Fig

Wegovy (semaglutide) functions primarily as a GLP-1 receptor agonist that increases insulin production, decreases glucagon secretion, and slows down gastric emptying

Tirzepatide is the most direct comparison, operating as a dual GIP/GLP-1 receptor agonist